SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001193125-21-192985
Filing Date
2021-06-17
Accepted
2021-06-17 13:41:29
Documents
1
Group Members
LAZARUS LIFE SCIENCES I, LLC

Document Format Files

Seq Description Document Type Size
1 SC 13D d148110dsc13d.htm SC 13D 54097
  Complete submission text file 0001193125-21-192985.txt   55627
Mailing Address 100 HIGH STREET 28TH FLOOR BOSTON MA 02110
Business Address 100 HIGH STREET 28TH FLOOR BOSTON MA 02110 617-349-1971
CATABASIS PHARMACEUTICALS INC (Subject) CIK: 0001454789 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-88910 | Film No.: 211024178
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2001 MARKET STREET, SUITE 2500 PHILADELPHIA PA 19103
Business Address 2001 MARKET STREET, SUITE 2500 PHILADELPHIA PA 19103 1-267-760-4066
Viridian, LLC (Filed by) CIK: 0001761506 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D